EPO/AMI-I Pilot Study Researchers. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction-randomized controlled pilot trial of EPO/AMI-1 study-
EPO/AMI-I Pilot Study Researchers. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction-randomized controlled pilot trial of EPO/AMI-1 study-
复制标题
EPO/AMI-I 试点研究研究人员。
作者：
Ozawa T;Toba K;Suzuki H;Kato K;Iso Y;Akutsu Y;Kobayashi Y;Takeyama Y;Kobayashi N;Yoshimura N;Akazawa K;Aizawa Y
